OLGA

Biomarker

1 paper2 findings

Associations

2

Future gastric cancer incidence

no changein humans1RR 1.2

1 study
  1. OLGA is associated with future gastric cancer incidence in humans (RR 1.20; 95% CI 0.85–1.69).

    “prospective cohort studies did not demonstrate a statistically significant increase in future GC incidence for OLGA II (RR 1.20; 95% CI 0.85-1.69).”

    ReviewProspective cohort studies; OLGA stage II; association not statistically significant

    Intermediate OLGA/OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta-Analysis

    Helicobacter1 Jan 2026

Gastric cancer

upin humans1OR 2.77

1 study
  1. OLGA is associated with gastric cancer in humans (OR 2.77; 95% CI 1.83–4.20).

    “Intermediate stages were also associated with GC in observational studies: OLGA II (OR 2.77; 95% CI 1.83-4.20; I2 = 71%)”

    ReviewObservational studies; OLGA stage II

    Intermediate OLGA/OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta-Analysis

    Helicobacter1 Jan 2026

More on Gastric cancer

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months